[go: up one dir, main page]

LT3520811T - Būdai, skirti atsmatikų priverstinio iškvėpimo tūrio padidinimui naudojant benralizumabą - Google Patents

Būdai, skirti atsmatikų priverstinio iškvėpimo tūrio padidinimui naudojant benralizumabą

Info

Publication number
LT3520811T
LT3520811T LTEP19158446.5T LT19158446T LT3520811T LT 3520811 T LT3520811 T LT 3520811T LT 19158446 T LT19158446 T LT 19158446T LT 3520811 T LT3520811 T LT 3520811T
Authority
LT
Lithuania
Prior art keywords
benralizumab
methods
exhaust volume
related exhaust
increasing related
Prior art date
Application number
LTEP19158446.5T
Other languages
English (en)
Inventor
Christine Ward
Lorin Roskos
Bing Wang
Donald Raible
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of LT3520811T publication Critical patent/LT3520811T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Endocrinology (AREA)
LTEP19158446.5T 2013-08-12 2014-08-07 Būdai, skirti atsmatikų priverstinio iškvėpimo tūrio padidinimui naudojant benralizumabą LT3520811T (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361864948P 2013-08-12 2013-08-12

Publications (1)

Publication Number Publication Date
LT3520811T true LT3520811T (lt) 2021-03-25

Family

ID=52448838

Family Applications (2)

Application Number Title Priority Date Filing Date
LTEP14836725.3T LT3033104T (lt) 2013-08-12 2014-08-07 Būdai, skirti astmatikų priverstinio iškvėpimo tūrio padidinimui naudojant bendralizumabą
LTEP19158446.5T LT3520811T (lt) 2013-08-12 2014-08-07 Būdai, skirti atsmatikų priverstinio iškvėpimo tūrio padidinimui naudojant benralizumabą

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LTEP14836725.3T LT3033104T (lt) 2013-08-12 2014-08-07 Būdai, skirti astmatikų priverstinio iškvėpimo tūrio padidinimui naudojant bendralizumabą

Country Status (26)

Country Link
US (1) US9441046B2 (lt)
EP (5) EP4579236A3 (lt)
JP (4) JP6746496B2 (lt)
KR (1) KR102337599B1 (lt)
CN (2) CN111588849A (lt)
AU (2) AU2014306959B2 (lt)
BR (1) BR112016002317A8 (lt)
CA (1) CA2917603C (lt)
CY (2) CY1122033T1 (lt)
DK (2) DK3033104T3 (lt)
ES (2) ES2866426T3 (lt)
HK (1) HK1222559A1 (lt)
HR (2) HRP20190920T1 (lt)
HU (2) HUE053627T2 (lt)
LT (2) LT3033104T (lt)
ME (1) ME03403B (lt)
MX (2) MX381102B (lt)
PL (2) PL3520811T3 (lt)
PT (2) PT3520811T (lt)
RS (2) RS58711B1 (lt)
RU (1) RU2703568C2 (lt)
SG (1) SG11201600483QA (lt)
SI (2) SI3033104T1 (lt)
SM (2) SMT202100152T1 (lt)
TR (1) TR201907907T4 (lt)
WO (1) WO2015023507A2 (lt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201600484TA (en) 2013-08-12 2016-02-26 Medimmune Llc Methods for improving asthma symptoms using benralizumab
CN105451760A (zh) 2013-08-12 2016-03-30 米迪缪尼有限公司 使用贝那利珠单抗降低哮喘恶化率的方法
EP3485902A1 (en) * 2013-10-15 2019-05-22 Astrazeneca AB Methods for treating chronic obstructive pulmonary disease using benralizumab
CA2926089C (en) * 2013-10-24 2022-08-30 Medimmune, Llc Stable, aqueous antibody formulations
TW202110479A (zh) * 2019-05-16 2021-03-16 瑞典商阿斯特捷利康公司 使用貝那利珠單抗治療增強型患者群體慢性阻塞性肺病之方法
TW202126688A (zh) * 2019-09-27 2021-07-16 瑞典商阿斯特捷利康公司 使用貝那利珠單抗治療遲發性氣喘之方法
TW202214692A (zh) * 2020-06-05 2022-04-16 瑞典商阿斯特捷利康公司 治療患有鼻瘜肉的患者的重度氣喘之方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1241944C (zh) 1995-09-11 2006-02-15 协和发酵工业株式会社 抗人白介素－5受体α链的抗体
US6746839B1 (en) * 1998-01-12 2004-06-08 Interleukin Genetics, Inc. Diagnostics and therapeutics for an obstructive airway disease
AU3672800A (en) 1999-04-09 2000-11-14 Kyowa Hakko Kogyo Co. Ltd. Method for controlling the activity of immunologically functional molecule
WO2001060405A1 (en) 2000-02-15 2001-08-23 Kyowa Hakko Kogyo Co., Ltd. Eosinophil-specific apoptosis inducer
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
US8093357B2 (en) 2002-03-01 2012-01-10 Xencor, Inc. Optimized Fc variants and methods for their generation
EP1688437A4 (en) 2003-10-08 2007-09-26 Kyowa Hakko Kogyo Kk ANTIBODY COMPOSITION SPECIFICALLY BINDING TO IL-5 RECEPTOR
US20060014680A1 (en) 2004-07-13 2006-01-19 Caiding Xu Peptides and compounds that bind to the IL-5 receptor
DK1931709T3 (en) 2005-10-03 2017-03-13 Xencor Inc FC VARIETIES WITH OPTIMIZED FC RECEPTOR BINDING PROPERTIES
ES2558689T3 (es) * 2007-05-14 2016-02-08 Medimmune, Llc Métodos para reducir los niveles de eosinófilos
RU2383345C1 (ru) * 2008-08-07 2010-03-10 Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Росздрава" (ГОУ ВПО "НИЖГМА РОСЗДРАВА") Способ лечения больных бронхиальной астмой
WO2012083132A2 (en) * 2010-12-16 2012-06-21 Genentech, Inc. Diagnosis and treatments relating to th2 inhibition
CN102544908B (zh) 2010-12-17 2016-01-06 富士康(昆山)电脑接插件有限公司 电连接器组件及插头连接器
EP2710370A4 (en) * 2011-05-18 2015-01-07 Medimmune Llc METHODS OF DIAGNOSING AND TREATING PULMONARY DISEASES OR DISORDERS
CA2853858A1 (en) 2011-11-01 2013-05-10 Medimmune, Llc Methods for reducing the frequency and severity of acute exacerbations of asthma
CN105451760A (zh) 2013-08-12 2016-03-30 米迪缪尼有限公司 使用贝那利珠单抗降低哮喘恶化率的方法
SG11201600484TA (en) 2013-08-12 2016-02-26 Medimmune Llc Methods for improving asthma symptoms using benralizumab

Also Published As

Publication number Publication date
US20150044203A1 (en) 2015-02-12
PL3033104T3 (pl) 2019-09-30
RS61565B1 (sr) 2021-04-29
PT3033104T (pt) 2019-06-27
RU2016108809A (ru) 2017-09-18
WO2015023507A3 (en) 2015-04-09
ES2733602T3 (es) 2019-12-02
AU2020201277A1 (en) 2020-03-12
JP2024129140A (ja) 2024-09-26
HK1222559A1 (zh) 2017-07-07
LT3033104T (lt) 2019-06-25
BR112016002317A2 (pt) 2017-12-12
PL3520811T3 (pl) 2021-08-02
EP3033104B1 (en) 2019-04-03
MX381102B (es) 2025-03-12
EP4636400A3 (en) 2025-12-24
EP3520811B1 (en) 2020-12-30
KR20160043049A (ko) 2016-04-20
RS58711B1 (sr) 2019-06-28
ES2866426T3 (es) 2021-10-19
CN105451769A (zh) 2016-03-30
SG11201600483QA (en) 2016-02-26
HRP20210406T1 (hr) 2021-04-30
RU2016108809A3 (lt) 2018-06-18
CY1122033T1 (el) 2020-10-14
AU2014306959A1 (en) 2016-02-04
KR102337599B1 (ko) 2021-12-10
EP4579236A2 (en) 2025-07-02
JP2020125304A (ja) 2020-08-20
PT3520811T (pt) 2021-03-15
RU2703568C2 (ru) 2019-10-21
HUE043497T2 (hu) 2019-08-28
MX2021003826A (es) 2021-05-27
JP6746496B2 (ja) 2020-08-26
DK3033104T3 (da) 2019-06-17
WO2015023507A8 (en) 2015-09-24
WO2015023507A2 (en) 2015-02-19
EP3875487A1 (en) 2021-09-08
DK3520811T3 (da) 2021-03-22
SI3520811T1 (sl) 2021-04-30
HUE053627T2 (hu) 2021-07-28
CY1124399T1 (el) 2022-07-22
HRP20190920T1 (hr) 2019-07-12
US9441046B2 (en) 2016-09-13
ME03403B (me) 2020-01-20
SMT201900311T1 (it) 2019-07-11
SI3033104T1 (sl) 2019-06-28
JP2016527325A (ja) 2016-09-08
SMT202100152T1 (it) 2021-05-07
MX2016001384A (es) 2016-08-03
TR201907907T4 (tr) 2019-06-21
EP3033104A2 (en) 2016-06-22
EP4636400A2 (en) 2025-10-22
CN111588849A (zh) 2020-08-28
AU2014306959B2 (en) 2019-11-21
HK1225300A1 (en) 2017-09-08
CA2917603A1 (en) 2015-02-19
JP2022120010A (ja) 2022-08-17
EP4579236A3 (en) 2025-09-17
EP3033104A4 (en) 2017-03-22
BR112016002317A8 (pt) 2018-06-12
CA2917603C (en) 2023-05-16
EP3520811A1 (en) 2019-08-07

Similar Documents

Publication Publication Date Title
LT3074534T (lt) Būdai, skirti polinukleotido sekoskaitai
IL246002A0 (en) Novel methods
DK3083694T3 (da) Caniniserede, murine anti-canin-pd-1-antistoffer
DE102013107115B8 (de) Schalldämpfer
IL245573B (en) Cell
FR3006466B3 (fr) .
CL2013001994S1 (es) Motocicleta
BR112014032116A2 (pt) método.
BR302014001378S1 (pt) Configuração aplicada em bolsa.
CL2014000309S1 (es) Motocicleta
CL2014000108S1 (es) Motocicleta
DK2975030T3 (da) Dihydropyridazin-3,5-dion-derivat
UA29891S (uk) Мотоцикл
LT3520811T (lt) Būdai, skirti atsmatikų priverstinio iškvėpimo tūrio padidinimui naudojant benralizumabą
FR3001302B1 (fr) .
EP2995538A4 (en) MOTORCYCLE
CL2014000196S1 (es) Motocicleta
DK3080385T3 (da) Forbedret lukkeapparat
DE112014001214A5 (de) Abgasanlage
FR3001303B1 (fr) .
EP2975687A4 (en) DUPLEXER
EP2970910A4 (en) Ablative immunotherapy
CL2015002282S1 (es) Encendedor
TH1401003564A (th) วิธีการสำหรับการยกกระดับก๊าซ
UY4313S (es) ?motocicleta?.